Viewing nowLipikrin Tablet 10mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
NBK Pharmaceutical Co., Ltd.

MFDS item code 201701877 · Approved 2017.04.17 · Insurance code 054800020
Improvement of hyperlipidemia (including familial forms); prevention of cardiovascular diseases (e.g., myocardial infarction)
This medication helps reduce the risk of cardiovascular disease. It lowers the risk of myocardial infarction, stroke, vascular interventions, and stable angina in adults aged 55 or older with multiple risk factors such as smoking, hypertension, low HDL cholesterol, and family history. It is also effective in reducing the risk of myocardial infarction and stroke in patients with type 2 diabetes who have risk factors for heart disease. In patients with existing coronary heart disease, it reduces the risk of myocardial infarction, stroke, vascular procedures, hospitalization due to congestive heart failure, and angina. Additionally, it lowers total cholesterol, LDL cholesterol, and triglycerides and raises HDL cholesterol in hyperlipidemic patients, assisting dietary management. It is specifically used to lower cholesterol levels in pediatric and adolescent patients with familial hypercholesterolemia. This medication is effective for improving cardiovascular health and treating hyperlipidemia.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients requiring greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (the 40 mg dose is only for patients requiring an LDL cholesterol reduction of 45% or more). This medicine is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients aged 70 years and older are generally similar to those in adult patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (10 ∼ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine above 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle-related problems; therefore, if symptoms of muscle pain or weakness arise, treatment should be stopped immediately, and consultation with a physician is required. Patients with impaired liver function or active liver disease should not take this medication. Women who are pregnant or may become pregnant should not take this medication and must use adequate contraceptive methods during treatment. Breastfeeding women should also avoid this medication and discontinue nursing. This medication is not for children under 10 years old. Patients with a history of alcohol abuse or liver disease should use this medication cautiously and undergo regular liver function tests. The risk of side effects may increase when taken with certain medications; hence, it is essential to inform a doctor or pharmacist if taking other medications. Severe muscle diseases such as myopathy or rhabdomyolysis may pose serious risks; therefore, if muscle pain is severe or persistent, inform medical personnel immediately. This medication can cause various side effects such as liver dysfunction, allergic reactions, skin rashes, gastrointestinal symptoms, etc.; if abnormal symptoms arise, consult a physician immediately. Elderly patients or those with poor kidney function are at higher risk of muscle-related side effects when taking this medication; caution is advised. There is no specific antidote for overdose; treatment should be symptomatic, and regular monitoring of liver function and muscle-related parameters should be conducted. This medication should be stored out of the reach of children and kept in its original container to maintain its quality and safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure and kept at room temperature between 1 and 30 degrees Celsius for safety. Storing it this way will maintain the drug's efficacy and prevent degradation.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
NBK Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.